China's A-shares performed steadily on Monday, monkeypox prevention and control concept stocks bucked the trend and surged

　　China News Service, Beijing, May 23 (Reporter Chen Kangliang) On the 23rd, the overall performance of China's A shares was stable, and the major stock indexes rose and fell, but the monkeypox prevention concept stocks rose against the trend, and related stocks performed well.

　　As of the close of the day, the monkeypox prevention and control concept sector had an overall increase of more than 8%.

Individual stocks such as West Point Pharmaceuticals and Haichen Pharmaceuticals all rose by more than 10%, and Zhijiang Bio, which is listed on the Science and Technology Innovation Board, gained a daily limit of 20%.

　　Zhijiang Bio said on the investor interaction platform that the monkeypox virus nucleic acid detection kit (fluorescent PCR method) developed by the company has obtained relevant EU certification, and the kit has already received small batch orders at home and abroad.

　　The spread of monkeypox virus continues to be of concern.

According to media reports, the number of countries reporting confirmed cases of monkeypox in this round has increased to 15.

　　The World Health Organization also recently issued an outbreak warning of monkeypox, saying that since cases have been found in many countries where the monkeypox virus is not endemic, more cases may be found in these countries and other countries in the future, and the monkeypox virus will spread further.

　　Dongguan Securities analyst Wei Hongmei said that recently, the United Kingdom and other countries have reported confirmed or suspected cases of human infection with monkeypox virus, and relevant testing reagent companies may have themed investment opportunities in the short term.

　　Chen Zhu, an analyst at CITIC Securities, said that the United States and Spain have purchased hundreds of millions of dollars worth of monkeypox vaccine as emergency reserves, and there is currently no specific drug for monkeypox. Monkeypox prevention and control concept stocks such as Zhijiang Bio are worthy of attention.

　　In terms of the overall performance of A-shares on the day, as of the close of the day, the Shanghai Composite Index reported 3146 points, an increase of 0.01%, and a turnover of 381.2 billion yuan (RMB, the same below); the Shenzhen Component Index reported 11447 points, a decrease of 0.06%, and a turnover of 478.5 billion yuan. Yuan; ChiNext Index was reported at 2410 points, down 0.3%.

(Finish)